Found 17 matching trials
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers
PHASE1This is a two-part randomized, placebo-controlled, observer-blind, safety a...
Status
Active Not Recruiting
Location
Centro de Investigação em Saúde de Manhiça (CISM) (recruiting participants for Part B only)
Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine
PHASE1This study aimed to evaluate the safety and reactogenicity of two intramusc...
Location
Gent University & Hospital, Center for Vaccinology
Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
PHASE1The HIV Vaccine Trials Network (HVTN) is doing a study to test 2 experiment...
Location
Emavundleni Desmond Tutu HIV Centre CRS
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
PHASE2This study will assess the safety and immunogenicity of GSK Biologicals' in...
Location
GSK Investigational Site
Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
PHASE1Our research is part of the global effort to develop a vaccine against HIV....
Location
Imperial College London
Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People
PHASE2A significant number of HIV infected patients in Africa also have dissemina...
Location
Muhimbili University College of Health Sciences
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
PHASE1This study will be done in people living with HIV to see if an investigatio...
Location
AIDS Clinical Trials Unit/The Ohio State University
A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines
PHASE1This study will test the immune system response to and safety of two HIV va...
Location
Alabama Vaccine CRS
Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
PHASE2The purpose of this study is to determine the safety, efficacy, and tolerab...
Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid
PHASE2This phase 2 study will evaluate the safety, immunogenicity and optimal tim...
Location
Desmond Tutu HIV Centre Cape Town